One test, one report, one price — regardless of order volume. Pricing for the restructured portfolio is being finalized; contact our team for current rates and volume terms.
Estimates 10- and 30-year risk of coronary heart disease using an ensemble polygenic score validated across ancestrally varied U.S. cohorts, integrated with family history.
Determines whether high LDL cholesterol is caused by an inherited variant (familial hypercholesterolemia). Polygenic score plus rare-variant classification for LDLR, APOB, PCSK9, and LDLRAP1.
Identifies whether severely elevated triglycerides stem from a rare inherited disorder. Polygenic score plus rare-variant classification for LPL, APOC2, APOA5, GPIHBP1, and LMF1.
Assesses inherited risk for chronic kidney disease with an ensemble polygenic score and APOL1 risk genotyping, integrated with family history.
Screens for inherited variants that raise the risk of venous thromboembolism, integrated with a VTE polygenic score. Includes F5 R506Q, F2 G20210A, and JAK2 V617F classification.
Assesses inherited risk for type 2 diabetes, combining an ensemble polygenic score, rare-variant signals, and family history.
Coronary heart disease · Chronic kidney disease · Hypertension · Venous thromboembolism · Abdominal aortic aneurysm · Atrial fibrillation · Type 2 diabetes
Ancestry-calibrated polygenic risk scores only — no rare-variant or family-history analysis — delivered in a single preventive report.
Sequencing performed by our partner lab — a CLIA-certified, CAP-accredited laboratory.
Prepaid return label included in every saliva kit.
Every report includes condition-specific interpretation guidance and suggested clinical actions.
Plain-language summary your patient can read before the follow-up appointment.
When variant classifications are updated or new evidence emerges, results are re-curated and ordering providers are notified. Re-analysis is included at no additional cost.
End-to-end encrypted storage. BAA executed with every clinical customer before the first order.
We are not yet in-network with any payer. Some patients have successfully submitted for HSA/FSA reimbursement. We provide a superbill on request.
No. Individual and Practice plans are pay-as-you-go. There is no minimum order quantity, no monthly fee, and no contract. Health System plans are contracted annually.
ARC-omix uses Blended Genome-Exome (BGE) sequencing, which is different from consumer genotyping arrays (23andMe, Ancestry) or clinical panel tests. We currently cannot accept raw data files from outside sources.
3–4 weeks from specimen receipt to report delivery. Expedited options (14 days for ARC-Cholesterol, 7 days for ARC-VTE) are available at an additional fee.
We re-run the test at no charge. If a second sample is needed, we send a new kit at our expense. QC failure rate is under 2%.